TMThais Soares Cianciarullo Minett

Thais Soares Cianciarullo Minett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thais Soares Cianciarullo Minett has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Language impairments in Alzheimer´s disease: What changes can be found between mild and moderate stages of the disease?

    by Karin Zazo Ortiz, Juliana Onofre De Lira, Thais Soares Ciariancullo Minett, Paulo Henrique Ferreira Bertolucci


  • Open Access

    Outcome study of the Pipeline Vantage Embolization Device (second version) in unruptured (and ruptured) aneurysms (PEDVU(R) study)

    by Thomas C Booth, Ahmed Bassiouny, Jeremy Lynch, Hemant Sonwalkar, Aaron Bleakley, Ahmed Iqbal, Thais Minett, Jonathon Buwanabala, Ana Paula Narata, Tufail Patankar, et al.

    Background The Pipeline Vantage Embolization Device (PEDV) is the fourth-generation pipeline flow diverter for intracranial aneurysm treatment. There are no outcome studies for the second PEDV version. We aimed to evaluate safety and efficacy outcomes. Primary and secondary objectives were to determine outcomes for unruptured and ruptured cohorts, respectively. Methods In this multicenter retrospective and prospective study, we analyzed outcome data from eight centers using core laboratory assessments. We determined 30-day and ≥3-month mortality and morbidity rates, and 6- and 18-month radiographic aneurysm occlusion rates for procedures performed during the period July 2021–March 2023. Results We included 121 consecutive patients with 131 aneurysms. The adequate occlusion rate for the unruptured cohort at short-term and medium-term follow up, and also for the ruptured cohort at short-term follow up, was >90%. Two aneurysms (1.5%) underwent retreatment. When mortality attributed to a palliative case in the unruptured cohort, or subarachnoid hemorrhage in the ruptured cohort, was excluded then the overall major adverse event rate in respective cohorts was 7.5% and 23.5%, with 0% mortality rates for each. When all event causes were included on an intention-to-treat basis, the major adverse event rates in respective cohorts were 8.3% and 40.9%, with 0.9% and 22.7% mortality rates. Conclusions For unruptured aneurysm treatment, the second PEDV version appears to have a superior efficacy and similar safety profile to previous-generation PEDs. These are acceptable outcomes in this pragmatic and non-industry-sponsored study. Analysis of ruptured aneurysm outcomes is limited by cohort size. Further prospective studies, particularly for ruptured aneurysms, are needed.


  • Open Access

    Language impairment in the moderate stage of dementia due to Alzheimer's disease

    by Karin Zazo Ortiz, Juliana Onofre DE Lira, Thais Soares Ciariancullo Minett, Paulo Henrique Ferreira Bertolucci

    Background: During the moderate stage of dementia due to Alzheimer’s disease (AD), language disorder is more evident and it impacts on communication. An overview of language impairment could be helpful to find compensatory communication strategies for these patients. Objective: To identify all language impairments among patients with moderate-stage of AD. Methods: 20 patients diagnosed with probable AD based on the criteria of the NINCDS-ARDRA, with a MMSE score of 13-23 points and CDR=2, who were undergoing treatment for AD with therapeutic doses of acetyl cholinesterase inhibitors, were assessed using the Boston Diagnostic Aphasia Examination (BDAE), a test that provides a broad assessment of language. The results were compared with the performance of a normal population. Results: The patients assessed in this study presented normal scores for oral and written word recognition, repetition, mechanics of writing, primer-level dictation and spelling to dictation but also had impairment at most levels of linguistic processing, in oral and written comprehension and production. In general, as expected, the tasks relying on access to the mental lexicon were most significantly affected. However, they performed well in the naming task, in which semantic cues were presented. Moreover, the patients assessed in this study had better performance in written comprehension tasks than in oral ones. Conclusion: The severity of the language impairments was not homogenous, with some linguistic abilities more impaired than others. The abilities that were found to be preserved can help to guide strategies for aiding in communication at this stage of AD.


  • Open Access

    Metaflammasome components in the human brain: a role in dementia with Alzheimer's pathology?

    by Mariko Taga, Thais Soares Cianciarullo Minett, John Classey, Fiona Matthews, Carol Brayne, Paul G Ince, James Ar Nicoll, Jacques Hugon, Delphine Boche, Mrc Cfas

  • Open Access

    Longitudinal diffusion tensor imaging changes in early Parkinson’s disease: ICICLE-PD study

    by Thais Minett, Li Su, Elijah Mak, Guy Williams, Michael Firbank, Rachael A. Lawson, Alison J. Yarnall, Gordon W. Duncan, Adrian M. Owen, Tien K. Khoo, et al.

    To investigate whether white matter microstructural changes can be used as a predictor of worsening of motor features or cognitive decline in patients with Parkinson’s disease and verify whether white matter microstructural longitudinal changes differ between patients with Parkinson’s disease with normal cognition and those with mild cognitive impairment.


  • Hippocampal sclerosis, hippocampal neuron loss patterns and Tdp-43 in the aged population

    by Suvi Hokkanen, Sally Hunter, Tm Polvikoski, Had Keage, Thais Soares Cianciarullo Minett, Fiona Matthews, Carol Brayne


  • Microglial immunophenotype in dementia with Alzheimer's pathology.

    by Thais Soares Cianciarullo Minett, John Classey, Fiona Matthews, Marie Fahrenhold, Mariko Taga, Carol Brayne, Paul G Ince, James Ar Nicoll, Delphine Boche, Mrc Cfas


  • Psychiatric symptoms may contribute to poor quality of life in adolescents with migraine

    by Joelma Karin Sagica Fernandes Paschoal, Jaime Lin, Ricardo Silva Pinho, Solange Andreoni, Thais Soares Cianciarullo Minett, Maria Sylvia de Souza Vitalle, Mauro Fisberg, Mario Fernando Prieto Peres, Luiz Celso Pereira Vilanova, Marcelo Rodrigues Masruha

    Background: The impact of migraine on quality of life (QOL) can be aggravated by other comorbid factors. The aim of the present study was to assess the differences in the QOL of adolescents with chronic migraine, episodic migraine, and healthy adolescents, and whether the differences in QOL among the diagnostic groups were associated with the presence of self‐reported psychiatric symptoms, such as depression and anxiety.Methods: A total of 157 adolescents (aged 15–19 years old) were included in the study. Fifty patients had episodic migraine, 56 patients suffered from chronic migraine, and 51 healthy adolescents were controls. All of the participants responded to a detailed headache questionnaire, the Medical Outcomes Trust 36‐Item Short‐form Health Survey, the State–Trait Anxiety Inventory and the Beck Depression Inventory.Results: Chronic migraine patients showed a significantly lower QOL than the control subjects in five dimensions of the Medical Outcomes Trust 36‐Item Short‐form Health Survey, and lower QOL than the episodic migraine patients in four dimensions. High levels of self‐reported depressive symptoms were associated with lower QOL in five dimensions and high levels of self‐reported anxiety were associated with lower QOL in four dimensions.Conclusions: The QOL of adolescent migraine sufferers may be aggravated not only by migraine but also by other factors, such as anxiety and depressive symptoms, which may contribute to the poor QOL in adolescents suffering from migraine.


  • Open Access

    Predicting risk of 2-year incident dementia using the CAMCOG total and subscale scores

    by Marialuisa Restaino, Fiona E. Matthews, Thais Minett, Emiliano Albanese, Carol Brayne, Blossom Christa Maree Stephan

    Background: being able to identify individuals at high risk of dementia is important for diagnostics and intervention. Currently, there is no standard approach to assessing cognitive function in older aged individuals to best predict incident dementia. Objective: to identify cognitive changes associated with an increased risk of 2-year incident dementia using the Cambridge Cognitive Examination (CAMCOG). Design: longitudinal population representative sample aged 65+ years. Methods: individuals were from the Medical Research Council Cognitive Function and Ageing Study. Classification and Regression Tree analysis was used to detect the optimal cut-off value for the CAMCOG total, subscales and composite memory and non-memory scores, for predicting dementia. Sensitivity and specificity of each cut-off score were assessed. Results: from the 2,053 individuals without dementia at the first assessment, 137 developed dementia at the 2-year follow-up. The results indicate similar discriminative accuracy for incident dementia based on the CAMCOG total, memory subscale and composite scores. However, sensitivity and specificity of cut-off values were generally moderate. Scores on the non-memory subscales generally had high sensitivity but low specificity. Compared with the CAMCOG total score they had significantly lower discriminative accuracy. Conclusion: in a population setting, cut-off scores from the CAMCOG memory subscales predicted dementia with reasonable accuracy. Scores on the non-memory scales have lower accuracy and are not recommend for predicting high-risk cases unless all non-memory subdomain scores are combined. The added value of cognition when assessed using the CAMCOG to other risk factors (e.g. health and genetics) should be tested within a risk prediction framework.


  • Adolescents with chronic migraine commonly exhibit depressive symptoms

    by Juliana Harumi Arita, Jaime Lin, Ricardo Silva Pinho, Thais Soares Cianciarullo Minett, Maria Sylvia de Souza Vitalle, Mauro Fisberg, Mario Fernando Prieto Peres, Luiz Celso Pereira Vilanova, Marcelo Rodrigues Masruha

    Psychiatric comorbidity in patients with headache contributes to poorer prognosis, chronification of disease, poor response to treatment, increased cost of treatment, and decreased quality of life. The purpose of the present study was to evaluate the depressive symptoms in adolescents with chronic and episodic migraines and healthy adolescents. The study was performed between November 2010 and November 2011. All patients completed a detailed headache questionnaire comprising of demographical and clinical data and were instructed to fill out a headache diary over a 2-month period. The subjects ranged in age from 13 to 19 years. To evaluate depression symptoms, all of the subjects were asked to fill out the Beck Depression Inventory (BDI). A total of 137 participants were evaluated; 44 had episodic migraine (EM), 46 had chronic migraine (CM) and 47 were control subjects. Patients with a history of chronic migraine had significantly higher scores on the BDI than the other participants. Patients with chronic migraine had BDI scores that were 8.8 points higher than controls [95 % CI (β) = 5.0, 12.6] and 5.8 points higher than patients with EM [95 % CI (β) = 2.2, 9.4]. The main finding of this study was that chronic migraine is strongly associated with depression symptoms, regardless of demographic data. Comorbid depression may increase the total burden of migraine and diagnosis and treatment of depression in adolescents with migraine is likely to result in a better prognosis.